We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-4 of 4

Federal court dismisses OTC drug litigation; reliance on agency warning letter misplaced
  • Shook Hardy & Bacon LLP
  • USA
  • September 16 2010

A federal court in Ohio has dismissed with prejudice a putative class action alleging that promotions for over-the-counter (OTC) cold- and flu-symptom relief products with vitamin C were false or misleading and violated state consumer protection laws.

Federal court rules coalition lacks standing to force FDA to stop allowing thimerosal in pharmaceuticals
  • Shook Hardy & Bacon LLP
  • USA
  • July 22 2010

A federal court in the District of Columbia has determined that an organization opposed to the use of mercury-based preservatives, such as Thimerosal, in vaccines, lacks standing to challenge in court the Food and Drug Administration's (FDA's) denial of its citizen petition seeking to ban the use of Thimerosal in pharmaceutical products, including vaccines.

Parts of defense expert witness testimony excluded in Children’s Tylenol litigation
  • Shook Hardy & Bacon LLP
  • USA
  • May 13 2010

A federal court in California has decided to exclude parts of the expert testimony proffered by a major retailer defending claims that Children's Tylenol Plus Multi-symptom Cold product caused the death of a 4-month-old child.